Prescription drug · NDA AUTHORIZED GENERIC
Sitagliptin NDC 70710-1900
Sitagliptin 50 mg/1 · Tablet · Oral · Zydus Pharmaceuticals (USA) Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-1900-3 | 70710190003 | 30 TABLET in 1 BOTTLE (70710-1900-3)Marketed from Nov 30, 2023 | |
| 70710-1900-9 | 70710190009 | 90 TABLET in 1 BOTTLE (70710-1900-9)Marketed from Nov 30, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sitagliptin
- Generic name (nonproprietary)
- sitagliptin
- Active ingredients
- Sitagliptin — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 211566
- Marketing start
- Listing expires
- Other FDA classes
- Dipeptidyl Peptidase 4 Inhibitors (Mechanism)
- Identifiers
- Product ID 70710-1900_c489d9fa-c7f0-473f-9f7b-77086e137e8fSPL ID c489d9fa-c7f0-473f-9f7b-77086e137e8fSPL set ID 6a970e80-b753-48fa-9fff-87e7a5044982RxCUI 665033, 665038, 665042UNII QFP0P1DV7ZUPC 0370710190095
- Pharmacologic class
- Dipeptidyl Peptidase 4 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470710190003followed by a unit qualifier and the quantityPackage 70710-1900-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sitagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Sitagliptin Tablets is not recommended in patients with type 1 diabetes mellitus. Sitagliptin Tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin Tablets. [see Warnings and Precautions (5.1) ]. Sitagliptin Tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( …
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 211566
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sitagliptin | Sitagliptin 25 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1899 |
| Sitagliptin | Sitagliptin 100 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1901 |
| Zituviositagliptin | Sitagliptin 50 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1241 |
| Zituviositagliptin | Sitagliptin 25 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1240 |
| Zituviositagliptin | Sitagliptin 100 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1242 |
| Zituviositagliptin | Sitagliptin 50 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1771 |
| Zituviositagliptin | Sitagliptin 25 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1770 |
| Zituviositagliptin | Sitagliptin 100 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1772 |
| Sitagliptin | Sitagliptin 25 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1790 |
| Sitagliptin | Sitagliptin 50 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1791 |
| Sitagliptin | Sitagliptin 100 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1792 |